Influenza restriction factor MxA functions as inflammasome sensor in the respiratory epithelium.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
25 10 2019
Historique:
received: 13 06 2018
revised: 21 06 2019
accepted: 19 09 2019
entrez: 27 10 2019
pubmed: 28 10 2019
medline: 30 7 2020
Statut: ppublish

Résumé

The respiratory epithelium is exposed to the environment and initiates inflammatory responses to exclude pathogens. Influenza A virus (IAV) infection triggers inflammatory responses in the respiratory mucosa, but the mechanisms of inflammasome activation are poorly understood. We identified MxA as a functional inflammasome sensor in respiratory epithelial cells that recognizes IAV nucleoprotein and triggers the formation of ASC (apoptosis-associated speck-like protein containing a CARD) specks via interaction of its GTPase domain with the PYD domain of ASC. ASC specks were present in bronchiolar epithelial cells of IAV-infected MxA-transgenic mice, which correlated with early IL-1β production and early recruitment of granulocytes in the lungs of infected mice. Collectively, these results demonstrate that MxA contributes to IAV resistance by triggering a rapid inflammatory response in infected respiratory epithelial cells.

Identifiants

pubmed: 31653718
pii: 4/40/eaau4643
doi: 10.1126/sciimmunol.aau4643
pii:
doi:

Substances chimiques

Inflammasomes 0
MX1 protein, human 0
Myxovirus Resistance Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

SangJoon Lee (S)

Department of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Akari Ishitsuka (A)

PhD Program in Human Biology, School of Integrative and Global Majors, University of Tsukuba, Tsukuba, Japan.

Masayuki Noguchi (M)

Department of Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Mikako Hirohama (M)

Department of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Yuji Fujiyasu (Y)

School of Medicine, University of Tsukuba, Tsukuba, Japan.

Philipp P Petric (PP)

Institute of Virology, University Medical Center Freiburg, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Spemann Graduate School of Biology and Medicine, University of Freiburg, Freiburg, Germany.

Martin Schwemmle (M)

Institute of Virology, University Medical Center Freiburg, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Peter Staeheli (P)

Institute of Virology, University Medical Center Freiburg, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Kyosuke Nagata (K)

Department of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

Atsushi Kawaguchi (A)

Department of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. ats-kawaguchi@md.tsukuba.ac.jp.
PhD Program in Human Biology, School of Integrative and Global Majors, University of Tsukuba, Tsukuba, Japan.
Transborder Medical Research Center, University of Tsukuba, Tsukuba, Japan.
Microbiology Research Center for Sustainability, University of Tsukuba, Tsukuba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH